Check patentability & draft patents in minutes with Patsnap Eureka AI!

Medicine uses of herpetone

A technology for the use of polone, which is applied in the field of chemical drugs and can solve problems such as reports on the medical use of bolengone that have not yet been seen.

Inactive Publication Date: 2008-12-03
CHENGDU UNIV OF TRADITIONAL CHINESE MEDICINE
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] There is no report on the medical use of polengone

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine uses of herpetone
  • Medicine uses of herpetone
  • Medicine uses of herpetone

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0009] The preparation of embodiment 1 polengone

[0010] Take 10 kg of dried and pulverized samples of pollen melon seeds, degrease with petroleum ether, and then heat and reflux extraction with 95% ethanol in a water bath (3 × 10 L), each time for 2 hours, distill the ethanol off under reduced pressure to obtain about 614 g of liquid extract. Add appropriate amount of quartz sand to the liquid extract and mix well, then place it in a Soxhlet extractor, heat and extract it with petroleum ether (boiling range 60-90°C), chloroform, ethyl acetate, and 95% ethanol in sequence, and depressurize the extract After recovery, 27g of chloroform extract, 32g of ethyl acetate extract and 195g of ethanol extract were obtained.

[0011] 20 g of the ethyl acetate extract was subjected to silica gel column chromatography with chloroform-methanol gradient elution. The fraction eluted with chloroform-methanol (99:1) was subjected to silica gel column chromatography, and the fraction eluted wi...

Embodiment 2

[0015] Example 2 The protective effect of polengone on DMSO-injured rat liver cells

[0016] Hepatic parenchymal cells were obtained by in vitro culture. Disperse the hepatic parenchymal cells with DMEM, and the cell count should not be less than 2×10 5 cells / ml, the cell viability was greater than 90%. Add the dispersed cells to the 96-well plate, 80 μl per empty.

[0017] In the experiment, 3 groups were set up, except for the blank control group, including the modeling group and the drug administration group, adding DMSO with a final concentration of 8mmol / L to each space to create a liver cell injury model; / ml, and incubated in a carbon dioxide incubator for 24 hours.

[0018] Incubate cells at 37°C, 5% CO 2 After culturing in the incubator for 24 hours, add 50 μl of MTT (0.25 mg / ml), 37°C, 5% CO 2 The incubator was cultured for 4 hours, the culture solution was aspirated, and then 150 μl of DMSO was added to stop the reaction, and the OD value was measured with a mi...

Embodiment 3

[0023] Embodiment 3 polengone is to CCl 4 Protective effect of injured rat liver cells

[0024] Hepatic parenchymal cells were obtained by in vitro culture. Disperse the hepatic parenchymal cells with DMEM, and the cell count should not be less than 2×10 5 cells / ml, the cell viability was greater than 90%. Add the dispersed cells to the 96-well plate, 80 μl per empty.

[0025] A total of 6 groups were set up in the experiment. In addition to the blank control group, including the modeling group and the drug administration group, CCl with a final concentration of 8mmol / L was added to each blank. 4 , to create a liver cell injury model; the administration group was added with polengone at a concentration of 0.5mg / ml, 0.25mg / ml, 0.125mg / ml, and 0.0625mg / ml, and placed in a carbon dioxide incubator for incubation for 24 hours.

[0026] Incubate cells at 37°C, 5% CO 2 After culturing in the incubator for 24 hours, add 50 μl of MTT (0.25 mg / ml), 37°C, 5% CO 2 The incubator was...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicinal application of a compound, namely herpetrione. The invention discloses the application of the herpetrione in preparation of medicines for liver damage resistance, liver cancer resistance and so on for the first time, in particular relating to the application of the herpetrione in preparation of medicines for treating the liver damage caused by chemical substances. The invention also provides a medicine which takes the herpetrione as an active ingredient, treats the liver damage and resists the liver cancer. The medicine provides a novel choice for clinic therapy of the liver damage and the liver cancer.

Description

technical field [0001] The invention relates to the medical application of compound polengone, belonging to the field of chemical medicine. Background technique [0002] Boling melon seeds are the dry mature seeds of the Cucurbitaceae plant Herpetospermum caudigerum Wall. It is a commonly used Tibetan medicine and has been included in the "Drug Standards of the Ministry of Health of the People's Republic of China" Tibetan medicine (Volume I). Boling melon seeds are bitter in taste and cold in nature. They can clear heat in the viscera and gallbladder heat. [0003] There are researches on the chemical composition of the melon seeds, foreign Kaouadji Mourad et al. reported that it contains benzofuran compounds: Herpetal, Herpetoriol; lignan compounds: lignan dimer (Herpetol), lignan trimer (Herpetrione), lignan tetramer (Herpetetradione, Herpetetrone), lignan pentamer (Herpepentol), etc. In China, Yuan Hailong et al. isolated bolensin from Boling melon seeds, and Zhang Mei ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/34A61P1/16A61P35/00
Inventor 张梅董小萍陈思敏张洪彬陈胡兰
Owner CHENGDU UNIV OF TRADITIONAL CHINESE MEDICINE
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More